Patient Access Solutions, Inc. (OTCMKTS: PASO) is heating up and running northbound after the Company affirmed it is moving forward with the long proposed Reverse Merger, currently at the signed Letter of Intent stage, with CLX Health as well as expansion of the core healthcare management business.
PASO rose up from sub pennies to highs of $0.169 earlier this year on excitement and anticipation of the planned CLX Health to reverse merge into PASO which has been delayed and is now expected to take place in Q4 2020 according to the document filed. CLX HealthCare Partners and JV Partners Sirius IQ is focused on next-gen Master Orchestration and Automation of data to streamline business processes, conversations, analytics and more. UST Global: is a multinational provider of Digital technology and transformation, IT services and solutions, headquartered in Aliso Viejo, California, United States. The Company has 23,000 employees and offices in over 25 countries including USA, India, Mexico, UK, Malaysia, Philippines, Singapore, Spain and Poland. UST Global has oriented its services around the following major platforms to offer our services in a Business Platform-as-a-Service (BPaaS) model while continuing to support enterprise-class customers with more traditional IT and BPO services.
Patient Access Solutions, Inc. (OTCMKTS: PASO) started off as a Healthcare Solutions company creating a formidable array of technology, management resources and allies to enable it to become an agent of radical change in what has traditionally been a slowly evolving healthcare environment.
PASO is a great RM candidate, the beefed up bod was accumulating stock on the open market and the Company does solid revenues and recently reported a net income of $190k for fiscal 2019 on revenues of $2.2 million. They also have little debt, and no convertible notes. RM stocks have been some of the hottest in small caps in recent years and PASO was no exception running from pennies to $0.169 highs and attracting legions of shareholders along the way.
To Find out the inside Scoop on PASO Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Microcapdaily has been reporting on PASO since March 2020 stating at the time “Its easy to see why investors are excited about PASO; the beefed up bod has been accumulating stock on the open market and the Company does solid revenues and recently reported a net income of $190k for fiscal 2019 on revenues of $2.2 million. They also have little debt, no convertible notes and recently updated shareholders on the previously announced LOI.”
PASO notified shareholders its authorized shares needs to be increased to 1,750,000,000 shares and provides the Company the flexibility to use a portion of these newly authorized shares to close the transaction with CLX, as well as with any other entity, by providing enough shares in the Treasury to issue a new series of Convertible Preferred shares envisioned to be priced at $15.00 per share.
The Company also approved two actions for its existing loyal shareholders as well as new prospective shareholders. Both these actions involve the new Series C Convertible Preferred Stock. The first is a dividend to all shareholders of record on September 18, 2020 at the close of the market. For every 5,000 shares of common stock then owned, each shareholder will receive one (1) Series C Convertible Preferred share. This equates to a 5% one-time dividend for any shareholder of record for every 5,000 shares owned. The second item the Company has authorized is a tender offer for all common shareholders of record on the same date. PASO and its Board have been actively pursuing additional transactions in addition to the LOI with CLX Health, LLC. We look forward to sharing the results as they become available.
We have a Monster Pick Coming. Subscribe Right Now!
Currently on the move up again PASO is an exciting story developing in small caps; RM stocks have been some of the hottest in small caps in recent years and PASO was no exception running from pennies to $0.169 highs and attracting legions of shareholders along the way. Since that time PASO saw a significant dip but is coming back strong after PASO announced on September 1 it is moving forward with the long proposed Reverse Merger, currently at the signed Letter of Intent stage, with CLX Health as well as expansion of the core healthcare management business. We will be updating on PASO when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with PASO.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in PASO either long or short and we have not been compensated for this article.